That interview right there that happened this evening is why my accumulation is increasing my holding because of how undervalued this is as a 6 million dollar EV and with 10 million in cash. The valuation is actually a joke compared to AGN at a 70 million dollar market cap with NYR with a far superior pre clinical study results and the mechanism of action is unique. NYR should be at all time highs on valuation right now but churning is good for rerating
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.025(10.6%) |
Mkt cap ! $54.83M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 26.5¢ | 23.5¢ | $352.7K | 1.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3600 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 4499 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |